ImageneBio (IMA) Net Income towards Common Stockholders (2020 - 2024)
Historic Net Income towards Common Stockholders for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to -$17.5 million.
- ImageneBio's Net Income towards Common Stockholders rose 1105.8% to -$17.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$53.5 million, marking a year-over-year increase of 2165.0%. This contributed to the annual value of -$49.2 million for FY2024, which is 2777.34% up from last year.
- As of Q4 2024, ImageneBio's Net Income towards Common Stockholders stood at -$17.5 million, which was up 1105.8% from -$6.2 million recorded in Q3 2024.
- Over the past 5 years, ImageneBio's Net Income towards Common Stockholders peaked at $2.8 million during Q4 2021, and registered a low of -$26.1 million during Q4 2020.
- Its 5-year average for Net Income towards Common Stockholders is -$13.5 million, with a median of -$14.4 million in 2021.
- As far as peak fluctuations go, ImageneBio's Net Income towards Common Stockholders surged by 11073.58% in 2021, and later plummeted by 60400.43% in 2022.
- Quarter analysis of 5 years shows ImageneBio's Net Income towards Common Stockholders stood at -$26.1 million in 2020, then surged by 110.74% to $2.8 million in 2021, then tumbled by 604.0% to -$14.1 million in 2022, then plummeted by 39.4% to -$19.7 million in 2023, then rose by 11.06% to -$17.5 million in 2024.
- Its last three reported values are -$17.5 million in Q4 2024, -$6.2 million for Q3 2024, and -$13.7 million during Q2 2024.